Iomeron 816 mg/mL (Iomeprol Injection INJECTION, SOLUTION) 816 mg/mL

Iomeron 816 mg/mL is an injectable solution used for diagnostic imaging procedures. This contrast agent enhances visibility during imaging, aiding in accurate diagnosis. Learn more about Iomeron's uses and effects.

Strength

816 mg/mL

Pack Size

6 BOTTLE, GLASS in 1 BOX (0270-9400-06) / 500 mL in 1 BOTTLE, GLASS

Manufacturer / TM Owner

BRACCO DIAGNOSTICS INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Iomeron 816 mg/mL is primarily used as a contrast medium for diagnostic imaging. It helps improve the clarity of images during procedures like CT scans and angiography. This injection is administered intravenously to enhance the visibility of blood vessels and organs. What is Iomeron used for? It is commonly utilized in medical imaging to provide detailed images for diagnostic purposes.

Side Effects

Common effects of Iomeron 816 mg/mL may include a warm sensation or mild discomfort at the injection site. Some individuals might experience temporary flushing or a metallic taste. These effects are generally short-lived and subside quickly. Always consult a healthcare provider for personalized information.

Precautions & Warnings

Iomeron 816 mg/mL should be handled with care, ensuring proper storage and administration. It is important to inform healthcare providers about any allergies or medical conditions before use. Follow the guidelines provided by the manufacturer for safe handling and disposal.

Avoid Interactions

Iomeron 816 mg/mL may interact with certain medications or substances. It is advisable to discuss all current medications with a healthcare provider before administration. Avoid combining with other contrast agents unless directed by a medical professional.

Frequently Asked Questions

Iomeron 816 mg/mL is used as a contrast agent for diagnostic imaging procedures, enhancing the visibility of blood vessels and organs.

Iomeron 816 mg/mL is administered intravenously by a healthcare professional during imaging procedures.

Common effects may include a warm sensation, mild discomfort at the injection site, or temporary flushing.

It is important to discuss all current medications with a healthcare provider to avoid potential interactions.

Iomeron should be stored as per the manufacturer's guidelines to ensure its effectiveness and safety.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.